Suppr超能文献

意大利根治性膀胱切除术注册研究(RIC)方案:一项非随机、24 个月、多中心研究,比较机器人辅助、腹腔镜和开放性手术治疗膀胱癌根治性膀胱切除术。

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer.

机构信息

Istituto Oncologico Veneto IRCCS, Padova, Italy.

Department of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, 00136, Rome, Italy.

出版信息

BMC Cancer. 2021 Jan 11;21(1):51. doi: 10.1186/s12885-020-07748-7.

Abstract

BACKGROUND

Bladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24 months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence.

METHODS

We describe a protocol for an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing radical cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with the recruitment phase between 1st January 2017-31st October 2020. Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24 months after radical cystectomy). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerve sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading, and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc).

DISCUSSION

The current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique.

TRIAL REGISTRATION

ClinicalTrials.gov , NCT04228198 . Registered 14th January 2020- Retrospectively registered.

摘要

背景

膀胱癌是全球第 9 常见的癌症类型。过去,根治性膀胱切除术经开放性手术被认为是肌层浸润性膀胱癌的金标准治疗方法。然而,近年来,机器人辅助腹腔镜根治性膀胱切除术的应用逐渐增加。本项目旨在研究比较三种不同手术技术(机器人辅助、腹腔镜和开放性手术)治疗膀胱癌患者的手术、肿瘤学和功能结果。将检查术前、术中和术后的因素,并对患者进行长达 24 个月的随访,以确定死亡率、肿瘤学结果、住院再入院、性功能和控尿的风险。

方法

我们描述了一项观察性、前瞻性、多中心、队列研究的方案,以评估接受根治性膀胱切除术和尿流改道术的膀胱癌患者。意大利根治性膀胱切除术登记处是一个电子登记处,用于前瞻性收集任何技术(开放性、腹腔镜、机器人辅助)进行根治性膀胱切除术患者的数据。意大利 28 个泌尿科部门将为该研究提供数据,招募阶段为 2017 年 1 月 1 日至 2020 年 10 月 31 日。在手术干预时和随访期间(根治性膀胱切除术后 3、6、12 和 24 个月)从患者处收集信息。围手术期变量包括手术时间、尿流改道术类型、转为开放性手术、出血、神经保留和淋巴结清扫术。随访数据收集包括组织学信息(例如,术后分期、分级和肿瘤组织学)、短期和长期结果(例如,死亡率、术后并发症、住院再入院、性能力、控尿等)。

讨论

目前的方案旨在为三种不同的膀胱癌根治性膀胱切除术手术技术的短期和长期结果提供额外的数据,包括开放性、腹腔镜和机器人辅助。这是一项比较有效性试验,考虑了一系列复杂的因素以及医生和患者的决策,这些因素会影响他们对手术技术的选择。

试验注册

ClinicalTrials.gov,NCT04228198。于 2020 年 1 月 14 日注册-回顾性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be46/7802145/c13ca6cf17fb/12885_2020_7748_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验